Thrilled to share DAPE-PD! We adapt autoregressive Evo1 into a bidirectional masked diffusion model to design functional promoters in three non-model gut bacteria. Huge thanks to our fantastic collaborators Lingpeng Kong @ikekong and Shansan Gong @sansa19739319 —what a team! 🚀. https://t.co/w4OC4mUvrX
There is more than one way to generate language.
In diffusion text models, from Dream 7B to Clover, we've been exploring what becomes possible when models can generate in parallel.
Proud to share our first release at DiffuSpace. 🍀
More importantly, we are still here.
One of the most amazing things I’ve ever seen: a standing ovation for the full Daraxonrasib results
I feel inspired and energised, to put it mildly — we have a targeted therapy for pancreatic cancer now, and nothing is undruggable anymore
Dr. Kanya Rajangam, Chief Medical Officer, emphasized that the encouraging SENTI-202 data support advancement into pivotal studies and exploration across additional patient populations, enabled by recent RMAT and Orphan Drug Designations.
https://t.co/T4H28dd2Ee
$SNTI #ASH2025
1/ Excited to share our new paper in Science: “Toward life with a 19-amino acid alphabet through generative artificial intelligence design.” @ColumbiaSysBio@ColumbiaBME@Columbia
https://t.co/ZT3Ygw9tiG 🦠🧬🛠️🖥️💥
🚀 Introducing Dream-VL & Dream-VLA!
We’re proving that dLLMs have an amazing advantage in building VLA models.
The result is stunning performance:
🏆 97.2% on LIBERO
⚡ 27x speedup vs AR models
🔥 Beats OpenVLA & $\pi_0$
✅ Fully Open Source
Blog: https://t.co/klCKlUeR1l
The world has lost one of the greatest physicists of the 20th century.
"Nature seems to take advantage of the simple mathematical representations of the symmetry laws"
Chen-Ning Yang (1922–2025)
Proud to share our lab’s first research paper, led by my incredible PhD student Shuchen Wang! 🎉 Huge thanks to our amazing collaborators for making this possible!! @ZijayTang
✨New preprint alert✨Ever tried baking sourdough at home? 🍞Fascinated by the magic of fermentation and the tiny microbes behind it? What if we could give them intelligence, logic, and teamwork across kingdom to treat complex gut disease? That’s the vision behind our SINERGY!
We’re grateful to IAI journal and ASM for the invitation. We summarized a range of CRISPR-based tools for studying host-microbe interactions. The article will be published soon!🥳
Know a rising star who studies host-microbe interactions? Nominate an exceptional early-career scientist to author a minireview in #IAIJournal’s 2026 New Voices in Microbiology Collection. Submit your nomination by Aug. 18: https://t.co/DnbZ8wksdV
Product update: Indel Analysis lets you score insertions/deletions across your sequence using PoET-2. You can now also compare multiple 3D structures in Mol* to evaluate design alternatives.
Sign up now: https://t.co/wNZPlwKMCJ
My dept in London at Imperial (Bioengineering) is recruiting a group leader at Professor level 🧑🎓 Please RT. It's a great department with world-class expertise in all sorts of biomedical & biological engineering topics, including synthetic biology. 🇬🇧https://t.co/LkS61qClUG
Super excited about the release of our open diffusion language model! Dream 7B has finally achieved the general language model capabilities I've been dreaming of since we started working on discrete diffusion models. Check out our blog post for details: https://t.co/2Fkr19qkrO
Excited to share PoET-2, our next breakthrough in protein language modeling. It represents a fundamental shift in how AI learns from evolutionary sequences. 🧵 1/13
Engineered cells are finding their way into agriculture, living materials, consumer products and medicines. How do we design these cells and adapt regulatory rules to facilitate their safe and efficient use? #synbio#biotech https://t.co/d88Y5h9EZY
Apply now, spread the word: three (3) fully funded Helmholtz research groups (assistant prof level) with attractive packages. Topics: RNA-based medicine, microbial RNA, and RNA-based infection research incl. RNA technologies. Great environment for young people. Come and join us.